David I Marks Selected Research

Cyclosporine (Ciclosporin)

1/2019	Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
1/2019	Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
10/2015	Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David I Marks Research Topics

Disease

31	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2023 - 04/2003
21	Leukemia 01/2021 - 11/2004
20	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 02/2006
15	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021 - 11/2004
11	Neoplasms (Cancer) 04/2022 - 02/2011
9	Bronchiolitis Obliterans Syndrome 04/2022 - 10/2005
9	Philadelphia Chromosome 01/2021 - 05/2009
8	Multiple Myeloma 08/2017 - 12/2003
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2022 - 03/2010
6	Lymphoma (Lymphomas) 12/2020 - 04/2003
6	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 06/2011
5	Pathologic Complete Response 01/2023 - 02/2012
5	Multiple Sclerosis 05/2022 - 09/2015
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 10/2008
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018 - 11/2009
4	Infections 01/2019 - 10/2003
4	Aplastic Anemia (Anemia, Hypoplastic) 05/2016 - 02/2011
3	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 03/2010
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 01/2020
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2014 - 12/2008
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2013 - 11/2003
2	Residual Neoplasm 05/2024 - 01/2019
2	Immunoglobulin Light-chain Amyloidosis 01/2021 - 08/2006
2	Rare Diseases (Rare Disease) 01/2020 - 11/2015
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 02/2006
2	Fever (Fevers) 01/2018 - 10/2003
2	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 01/2009
2	Invasive Fungal Infections 02/2017 - 01/2017
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2013 - 10/2010
2	Neutropenia 08/2012 - 10/2003
1	Amyloidosis 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020
1	monosomy Chromosome 7 01/2020
1	Seizures (Absence Seizure) 01/2019
1	Histiocytic Sarcoma 01/2018
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2018
1	Sickle Cell Anemia (Hemoglobin S Disease) 11/2017
1	Infertility (Sterility) 08/2017
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 08/2017
1	Stroke (Strokes) 08/2017
1	Cataract (Cataracts) 08/2017
1	Hypothyroidism 08/2017

Drug/Important Bio-Agent (IBA)

8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 04/2006
8	fludarabineIBA 01/2023 - 06/2005
8	Inotuzumab OzogamicinIBA 01/2021 - 08/2017
8	Alemtuzumab (Campath)FDA Link 12/2020 - 06/2005
6	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 06/2005
6	Busulfan (Busulfex)FDA Link 11/2021 - 12/2013
4	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020 - 02/2006
4	AntigensIBA 01/2019 - 11/2004
3	Rituximab (Mabthera)FDA Link 04/2022 - 11/2009
3	SteroidsIBA 01/2020 - 10/2018
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 06/2005
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 10/2015
3	Calcineurin InhibitorsIBA 01/2019 - 01/2018
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 10/2015
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 10/2015
3	Voriconazole (Vfend)FDA LinkGeneric 01/2017 - 11/2011
3	Imatinib Mesylate (Gleevec)FDA Link 02/2014 - 10/2008
3	HLA Antigens (Human Leukocyte Antigens)IBA 12/2013 - 03/2009
2	Monoclonal AntibodiesIBA 04/2022 - 11/2009
2	Bortezomib (Velcade)FDA Link 01/2021 - 02/2017
2	Etoposide (VP 16)FDA LinkGeneric 12/2020 - 04/2006
2	CalicheamicinsIBA 01/2019 - 01/2018
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 01/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018 - 08/2017
2	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018 - 08/2017
2	AzolesIBA 02/2017 - 03/2015
2	Antifungal AgentsIBA 01/2017 - 05/2003
2	Itraconazole (Sporanox)FDA LinkGeneric 03/2015 - 11/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	tisagenlecleucelIBA 12/2021
1	Carmustine (FIVB)FDA Link 12/2020
1	nelarabine (506U78)FDA Link 01/2020
1	remestemcel-lIBA 01/2020
1	HLA-A Antigens (HLA-A)IBA 01/2019
1	2-aminoethylmethyl sulfoneIBA 01/2019
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2019
1	Untranslated Regions (Untranslated Region)IBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	PerforinIBA 11/2017
1	Growth Hormone (Somatotropin)IBA 08/2017
1	Alkylating AgentsIBA 08/2017
1	BilirubinIBA 08/2017

Therapy/Procedure

51	Cell Transplantation 10/2023 - 02/2006
35	Transplantation 04/2022 - 04/2003
31	Therapeutics 04/2022 - 04/2008
20	Hematopoietic Stem Cell Transplantation 01/2021 - 11/2003
18	Stem Cell Transplantation 01/2023 - 10/2002
17	Homologous Transplantation 01/2019 - 02/2006
16	Drug Therapy (Chemotherapy) 10/2019 - 08/2006
9	Autologous Transplantation 02/2017 - 02/2006
5	Induction Chemotherapy 01/2021 - 03/2006
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2018 - 04/2003
3	Immunotherapy 05/2024 - 11/2014
2	Intravenous Infusions 05/2022 - 09/2015
2	Donor Selection 03/2022 - 01/2019
2	Salvage Therapy 01/2020 - 08/2017
1	Aftercare (After-Treatment) 08/2017